Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (649)	12/5/2001 2:34:01 PM
From: Tomato	Read Replies (1) \| Respond to of 1833

You have a good point. I was just thinking that BMY might know something we don't (can't think of what that could be, but then again, I can't think of a good reason for them to have sold shares, either). Also, I've been programmed by reading TA books to think that up is good/healthy and down is sick/bad (which it can indeed signify some of the time). I know you figure that if nothing happens re a sale it could be a positive in the long run what with potential royalty income and positive developments in Axiom, but then again, "a bird in the hand....." and I'd rather have $2.50- $3/sh now than what might turn out to be a depreciated asset later if Axiom and royalties don't pan out. Cheers